AMRN
Price
$1.06
Change
-$0.01 (-0.93%)
Updated
Mar 1, 6:59 PM EST
60 days until earnings call
LIAN
Price
$4.88
Change
+$0.04 (+0.83%)
Updated
Mar 1, 6:59 PM EST
24 days until earnings call
Ad is loading...

Compare predictions AMRN vs LIAN

Header iconAMRN vs LIAN Comparison
Open Charts AMRN vs LIANBanner chart's image
Amarin
Price$1.06
Change-$0.01 (-0.93%)
Volume$2.47M
CapitalizationN/A
LianBio
Price$4.88
Change+$0.04 (+0.83%)
Volume$127.36K
CapitalizationN/A
View a ticker or compare two or three
AMRN vs LIAN Comparison Chart

Loading...

AMRNDaily Signal changed days agoGain/Loss if shorted
 
Show more...
LIANDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
AMRN vs. LIAN commentary
Mar 02, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMRN is a Hold and LIAN is a Buy.

COMPARISON
Comparison
Mar 02, 2024
Stock price -- (AMRN: $1.06 vs. LIAN: $4.88)
Brand notoriety: AMRN: Notable vs. LIAN: Not notable
AMRN represents the Pharmaceuticals: Major, while LIAN is part of the Biotechnology industry
Current volume relative to the 65-day Moving Average: AMRN: 104% vs. LIAN: 21%
Market capitalization -- AMRN: $538.95M vs. LIAN: $524.1M
AMRN [@Pharmaceuticals: Major] is valued at $538.95M. LIAN’s [@Biotechnology] market capitalization is $524.1M. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $716.12B to $0. The market cap for tickers in the [@Biotechnology] industry ranges from $541.24B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $85.06B. The average market capitalization across the [@Biotechnology] industry is $2.59B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AMRN’s FA Score shows that 0 FA rating(s) are green whileLIAN’s FA Score has 1 green FA rating(s).

  • AMRN’s FA Score: 0 green, 5 red.
  • LIAN’s FA Score: 1 green, 4 red.
According to our system of comparison, LIAN is a better buy in the long-term than AMRN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AMRN’s TA Score shows that 4 TA indicator(s) are bullish while LIAN’s TA Score has 6 bullish TA indicator(s).

  • AMRN’s TA Score: 4 bullish, 6 bearish.
  • LIAN’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, LIAN is a better buy in the short-term than AMRN.

Price Growth

AMRN (@Pharmaceuticals: Major) experienced а -10.92% price change this week, while LIAN (@Biotechnology) price change was +1.88% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was -2.34%. For the same industry, the average monthly price growth was -0.99%, and the average quarterly price growth was -5.67%.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.02%. For the same industry, the average monthly price growth was +20.20%, and the average quarterly price growth was +48.09%.

Reported Earning Dates

AMRN is expected to report earnings on May 01, 2024.

LIAN is expected to report earnings on May 09, 2024.

Industries' Descriptions

@Pharmaceuticals: Major (-2.34% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

@Biotechnology (+7.02% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for AMRN with price predictions.
OPEN
A.I.dvisor published
a Summary for LIAN with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
AMRN($539M) and LIAN($524M) have the same market capitalization . AMRN has higher P/E ratio than LIAN: AMRN (67.11) vs LIAN (1.55). AMRN YTD gains are higher at: 21.839 vs. LIAN (9.172). AMRN has higher annual earnings (EBITDA): -70.23M vs. LIAN (-105.26M). AMRN has more cash in the bank: 321M vs. LIAN (252M). LIAN has less debt than AMRN: LIAN (2.84M) vs AMRN (8.97M). AMRN has higher revenues than LIAN: AMRN (322M) vs LIAN (0).
AMRNLIANAMRN / LIAN
Capitalization539M524M103%
EBITDA-70.23M-105.26M67%
Gain YTD21.8399.172238%
P/E Ratio67.111.554,323%
Revenue322M0-
Total Cash321M252M127%
Total Debt8.97M2.84M316%
FUNDAMENTALS RATINGS
AMRN: Fundamental Ratings
AMRN
OUTLOOK RATING
1..100
2
VALUATION
overvalued / fair valued / undervalued
1..100
89
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
92
PRICE GROWTH RATING
1..100
50
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AMRNLIAN
RSI
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
85%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
79%
MACD
ODDS (%)
Bearish Trend 1 day ago
85%
Bullish Trend 1 day ago
79%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
87%
Bullish Trend 1 day ago
82%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
86%
Bullish Trend 1 day ago
82%
Advances
ODDS (%)
Bullish Trend 4 days ago
74%
Bullish Trend 1 day ago
81%
Declines
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 23 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
86%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
81%
View a ticker or compare two or three
Ad is loading...
AMRNDaily Signal changed days agoGain/Loss if shorted
 
Show more...
LIANDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FBTAX30.35N/A
N/A
Fidelity Advisor Biotechnology A
RSIFX22.43N/A
N/A
Victory RS Science and Technology A
DHFAX12.56N/A
N/A
Diamond Hill Large Cap Concentrated Inv
FNILX18.06N/A
N/A
Fidelity ZERO Large Cap Index
RTDCX17.55N/A
N/A
Russell Inv Multifactor US Equity C

AMRN and

Correlation & Price change

A.I.dvisor indicates that over the last year, AMRN has been loosely correlated with KZR. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if AMRN jumps, then KZR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AMRN
1D Price
Change %
AMRN100%
-0.47%
KZR - AMRN
56%
Loosely correlated
-0.96%
CNTB - AMRN
55%
Loosely correlated
-2.54%
HRTX - AMRN
44%
Loosely correlated
-1.51%
MGNX - AMRN
44%
Loosely correlated
+6.24%
ALXO - AMRN
43%
Loosely correlated
+2.24%
More